vTv Therapeutics Inc. (VTVT): Nasdaq/NYSE listing notice — vTv Therapeutics receives Nasdaq deficiency notice for bid price below $1.00 per share

vTv Therapeutics Inc.

Received Nasdaq letter on Dec 22, 2022, citing non-compliance with Rule 5550(a)(2) due to closing bid below $1.00 for 30 consecutive business days.
Has 180 calendar days, until June 20, 2023, to regain compliance by closing bid at or above $1.00 for 10 consecutive business days.
Company is evaluating options to regain compliance; if unsuccessful, stock may be delisted from Nasdaq Capital Market.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

vTv Therapeutics Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

December 22, 2022, vTv Therapeutics Inc. (the “Company”) received a letter from The NASDAQ Stock Market LLC (“NASDAQ”) notifying the Company that it is not in compliance with the requirement of NASDAQ Rule 5550(a)(2) as a result of the closing bid price of the Company’s Class A common stock (“Class A Common Stock”) being below $1.00 per share for 30 consecutive business days. This notification has no effect on the listing of the Class A Common Stock on The NASDAQ Capital Market at this time. In accordance with NASDAQ Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until June

View on SEC.gov

Browse all listing & compliance notices →

vTv Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0000950142-22-003473

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.